You are here: Industry Insights > gene

News List

FDA approves first gene therapy for paediatric spinal muscular atrophy europeanpharmaceuticalreview
May 30, 2019
The FDA has given approval to AveXis for the first treatment of paediatric spinal muscular atrophy (SMA).
Do You Have the 'Fainting Gene'? drugs
May 29, 2019
Some folks are more prone to fainting than others, and the reason might lie in their DNA.
Vineti Opens New Regional HQ in Maryland contractpharma
May 29, 2019
New office expansion further enables accelerated cell and gene therapy clinical development and commercial operations in the Eastern United States.
FDA Approves First Gene Therapy Zolgensma (Onasemnogene Abeparvovec-xioi) for Spinal Muscular Atrophy drugs
May 29, 2019
FDA Approves First Gene Therapy Zolgensma (Onasemnogene Abeparvovec-xioi) for Spinal Muscular Atrophy.
Do You Have the 'Fainting Gene'? drugs
May 29, 2019
Some folks are more prone to fainting than others, and the reason might lie in their DNA.
New Gene Variants for Type 2 Diabetes Found drugs
May 24, 2019
New Gene Variants for Type 2 Diabetes Found.
Catalent Completes Paragon Acquisition contractpharma
May 21, 2019
$1.2 billion deal for gene therapy leader is final.
Solid tanks as safety scare again rocks DMD gene therapy fiercebiotech
May 15, 2019
A safety scare has rocked Solid Biosciences’ drive to get its Duchenne muscular dystrophy (DMD) gene therapy program back on track.
Prostate cancer mutation found to triple risk of death pharmatimes
May 09, 2019
Prostate cancer mutation found to triple risk of death.
Microcapsules to enhance the efficiency of genome-editing europeanpharmaceuticalreview
May 06, 2019
Researchers have found that polymer and hybrid silica-coated microcapsules are efficient in genome-editing…

Previous page 1 2 3 4 5 6 7 8 9 10 Next page